CLECL1 anticorps (N-Term)
Aperçu rapide pour CLECL1 anticorps (N-Term) (ABIN631187)
Antigène
Voir toutes CLECL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- CLECL1 antibody was raised against the N terminal of CLECL1
-
Purification
- Affinity purified
-
Immunogène
- CLECL1 antibody was raised using the N terminal of CLECL1 corresponding to a region with amino acids MVSNFFHVIQVFEKSATLISKTEHIGFVIYSWRKSTTHLGSRRKFAISIY
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CLECL1 Blocking Peptide, (ABIN5612926), is also available for use as a blocking control in assays to test for specificity of this CLECL1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CLECL1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CLECL1 (C-Type Lectin-Like 1 (CLECL1))
-
Autre désignation
- CLECL1
-
Sujet
- DCAL1 is a type II transmembrane, C-type lectin-like protein expressed on dendritic cells (DCs) and B cells. It interacts with subsets of T cells as a costimulatory molecule that enhances interleukin-4 production.
-
Poids moléculaire
- 19 kDa (MW of target protein)
Antigène
-